These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 754993

  • 21. Haemostatic changes and the oral contraceptive pill.
    Norris LA, Bonnar J.
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):545-64. PubMed ID: 9488791
    [Abstract] [Full Text] [Related]

  • 22. Low-dose oral contraceptive usage and coagulation.
    Notelovitz M, Kitchens CS, Coone L, McKenzie L, Carter R.
    Am J Obstet Gynecol; 1981 Sep 01; 141(1):71-5. PubMed ID: 6168202
    [Abstract] [Full Text] [Related]

  • 23. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K, Kamal I, Talaat MM, Rashad S, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun 01; 5(1):41-65. PubMed ID: 12256027
    [Abstract] [Full Text] [Related]

  • 24. Oral contraceptives.
    Maclennan AH.
    Curr Ther (Seaforth); 1987 Dec 01; 28(12):113-22. PubMed ID: 12317413
    [Abstract] [Full Text] [Related]

  • 25. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
    Prasad RN, Koh S, Ratnam SS.
    Contraception; 1989 Apr 01; 39(4):369-83. PubMed ID: 2524360
    [Abstract] [Full Text] [Related]

  • 26. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA, Kazi AB, Kazi A, Ali N.
    J Pak Med Assoc (1951); 1972 Aug 01; 22(8):218-25. PubMed ID: 12305803
    [Abstract] [Full Text] [Related]

  • 27. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Aug 01; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 28. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B.
    N Engl J Med; 1983 Apr 14; 308(15):862-7. PubMed ID: 6572785
    [Abstract] [Full Text] [Related]

  • 29. Vaginal administration of a combined oral contraceptive containing norethisterone acetate.
    Souka AR, Kamel M, Einen MA, Saleh F, Sallam H.
    Contraception; 1985 Jun 14; 31(6):571-81. PubMed ID: 3899504
    [Abstract] [Full Text] [Related]

  • 30. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
    United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion.
    Contraception; 2003 Sep 14; 68(3):159-76. PubMed ID: 14561536
    [Abstract] [Full Text] [Related]

  • 31. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R.
    J Clin Endocrinol Metab; 1995 Jun 14; 80(6):1816-21. PubMed ID: 7775629
    [Abstract] [Full Text] [Related]

  • 32. Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
    Weir RJ.
    Scott Med J; 1982 Jul 14; 27(3):212-5. PubMed ID: 6810459
    [Abstract] [Full Text] [Related]

  • 33. Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism.
    Coata G, Ventura F, Lombardini R, Ciuffetti G, Cosmi EV, Di Renzo GC.
    Contraception; 1995 Sep 14; 52(3):151-7. PubMed ID: 7587186
    [Abstract] [Full Text] [Related]

  • 34. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J, Kluft C.
    Thromb Haemost; 1985 Aug 30; 54(2):454-9. PubMed ID: 2417350
    [Abstract] [Full Text] [Related]

  • 35. Effects of oral contraceptives on blood coagulation. A review.
    Beller FK, Ebert C.
    Obstet Gynecol Surv; 1985 Jul 30; 40(7):425-36. PubMed ID: 3895067
    [Abstract] [Full Text] [Related]

  • 36. Oral contraceptives and blood coagulation.
    Bonnar J, Sabra AM.
    J Reprod Med; 1986 Jun 30; 31(6 Suppl):551-6. PubMed ID: 2941571
    [Abstract] [Full Text] [Related]

  • 37. Progestational agents and blood coagulation. VIII. Effect of low-dose, alternate-day, estrogen-progestin combinations on blood coagulation factors in man, with a special note on the effect of freezing of blood samples.
    Ambrus JL, Courey NG, Browne BJ, Mink IB, Moore RH, Ambrus CM.
    Am J Obstet Gynecol; 1977 May 15; 128(2):161-6. PubMed ID: 857675
    [Abstract] [Full Text] [Related]

  • 38. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov 15; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 39. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC, Montes MB, Franceschini SA, Toloi MR.
    Int J Fertil Womens Med; 2001 Nov 15; 46(5):265-70. PubMed ID: 11720199
    [Abstract] [Full Text] [Related]

  • 40. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA, Dubnitskaia LV, Korsakov SG.
    Akush Ginekol (Mosk); 1989 Jul 15; (7):48-51. PubMed ID: 2478038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.